Brady James Aloysius
- SEC CIK
- 0001916987
In the past year, 1 open-market sale filing worth $60.0K and no purchases.
Current role at each company
- XERS Xeris Biopharma Holdings, Inc.Directoras of Jun 5, 2026
- VRNA Verona Pharma plcDirectoras of Oct 8, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $60.0K
- 1 filing
- Net
- −$60.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Brady James Aloysius as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XERS Xeris Biopharma Holdings, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 (view filing) | Mar 30 | 2 days | Brady James AloysiusDirector | SSale | −10.8K | $5.54 | −$60.0K | −10.8%89.2K after | 10b5-1 |
VRNA Verona Pharma plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 (view filing) | Aug 1 | 4 days | Brady James AloysiusDirector | SSale | −824 | $13.14 | −$10.8K | −3.4%23.2K after |